ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
155 hedge funds and large institutions have $1.08B invested in Intercept Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 64 increasing their positions, 38 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
57% less capital invested
Capital invested by funds: $2.5B → $1.08B (-$1.42B)
Holders
155
Holding in Top 10
1
Calls
$117M
Puts
$94.1M
Top Buyers
| 1 | +$33.9M | |
| 2 | +$22.4M | |
| 3 | +$15.8M | |
| 4 |
JG
Jefferies Group
New York
|
+$14.9M |
| 5 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$13.3M |
Top Sellers
| 1 | -$246M | |
| 2 | -$65.4M | |
| 3 | -$32.2M | |
| 4 |
O
OrbiMed
New York
|
-$27.3M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$13.5M |